Bae Ji Hyun, Shim Jung-Hyun, Cho Young Sik
College of Pharmacy, Keimyung University, 1000 Sindang-dong, Dalseo-gu, Daegu, 704-701, South Korea.
Arch Pharm Res. 2014 Jun;37(6):689-97. doi: 10.1007/s12272-014-0385-6. Epub 2014 Apr 10.
Necroptosis is an active and well-orchestrated necrosis, distinctive from apoptosis in microscopic structure, and biochemical and molecular features. Unlike apoptosis-undergoing cells, which are removed by macrophage or neighboring cells, necrotic cell death releases danger signals and provokes inflammation, and further a severe damage to neighbor tissue. A regulated necrosis, termed as necroptosis or programmed necrosis, is emerging as a new paradigm of cell death that can be activated when apoptotic machinery is genetically or pathogenically defective. It plays biological significances in pathogenesis of a variety of inflammatory diseases as well as in a beneficial innate immune defense mechanism. This review highlights the identification of hits against necroptosis, and comprehensive approaches to discovery of small molecules that regulate necroptotic cell death. Also, the signaling molecular mechanism of necroptosis and future clinical uses of necroptosis inhibitor will be described in brief.
坏死性凋亡是一种活跃且精心编排的坏死过程,在微观结构、生化及分子特征方面有别于凋亡。与通过巨噬细胞或邻近细胞清除的凋亡细胞不同,坏死性细胞死亡会释放危险信号并引发炎症,进而对邻近组织造成严重损伤。一种被称为坏死性凋亡或程序性坏死的调控性坏死,正作为一种新的细胞死亡范式出现,当凋亡机制在基因上或因病原体而存在缺陷时,它就会被激活。它在多种炎症性疾病的发病机制以及有益的固有免疫防御机制中都具有生物学意义。本综述重点介绍了针对坏死性凋亡的研究成果,以及发现调控坏死性细胞死亡的小分子的综合方法。此外,还将简要描述坏死性凋亡的信号分子机制以及坏死性凋亡抑制剂未来的临床应用。